Patients with stroke have a high prevalence of depression and unawareness of emotions or alexithymia. Here we investigated the effects of the serotoninergic and noradrenergic reuptake inhibitor (SNRI) venlafaxine in comparison with the SSRI fluoxetine on alexithymia severity in patients with DSM-IV post-stroke major depressive-like episode (PSD).
Cravello, L., Caltagirone, C., Spalletta, G. (2009). The SNRI venlafaxine improves emotional unawareness in patients with post-stroke depression. HUMAN PSYCHOPHARMACOLOGY, 24(4), 331-336 [10.1002/hup.1021].
The SNRI venlafaxine improves emotional unawareness in patients with post-stroke depression
CALTAGIRONE, CARLO;
2009-06-01
Abstract
Patients with stroke have a high prevalence of depression and unawareness of emotions or alexithymia. Here we investigated the effects of the serotoninergic and noradrenergic reuptake inhibitor (SNRI) venlafaxine in comparison with the SSRI fluoxetine on alexithymia severity in patients with DSM-IV post-stroke major depressive-like episode (PSD).File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
